Abstract: The present invention relates to the use of proteins, enzymes and probiotics to create a wholistic system that prevents negative effects of protein indigestion on gut microbiota and improves diversity and count of gut microbiota, thereby promoting microflora balance. The invention, in one or more embodiments, increases the bioavailability of postbiotics that regulate health, including, skin health, stress, anxiety and depression, physical endurance, healthy aging, inflammation and cardiac health. The invention, in one or more embodiments, also increases the bioavailability of essential, non-essential and branched amino acids.

Abstract: An oral fibrinolytic composition comprising the enzymes serrapeptase and nattokinase. The composition treats and/or may prevent fibrosis conditions and their related symptoms in animals, including humans. This composition may further comprise of one or more enzymes, bioflavonoids, vitamins, coenzymes, minerals, probiotics, prebiotics, herbs, excipients and/or combinations thereof. The composition may improve lung capacity, oxygen saturation, vigor, and/or lung function. It may further alleviate dyspnea, limitations and fear caused by dyspnea, cough, phlegm, fatigue, body pain, chest discomfort, anxiety, depression, loss of appetite, and/or respiratory disorders. The composition of serrapeptase and nattokinase and/or one or more additional component may improve immune health, sleep, health-related quality of life (HRQoL), social well-being, health status, mental health and/or exercise capacity.